For reprint rights or to purchase a copy of your Daily Journal photo, email Jeremy_Ellis@dailyjournal.com for prices or call 213-229-5424.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Administrative/Regulatory

Jun. 25, 2011

Virtual Clinical Trials Raise Legal and Ethical Questions

Pfizer Inc. will conduct the first-ever "virtual" clinical trial using mobile devices and the Internet rather than in-person doctor visits to collect data from patients taking Detrol LA in a study that raises legal and ethical questions.


By Mandy Jackson


Daily Journal Staff Writer


Researchers will never meet in person with patients in a newly developed "virtual" clinical drug trial, raising serious legal and ethical questions.


New York City-based Pfizer Inc. announced earlier this month that it would conduct the first-ever virtual clinical trial using Detrol LA, an overactive bladder drug. The study will use mobile devices and Internet technology rather than in-perso...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.